U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Dextrose 25% Injection
Status: Currently in Shortage
»Date first posted: 02/07/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Hospira, Inc., a Pfizer Company (Revised 11/28/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.5 g/10 mL (250 mg/mL), plastic syringe, 10 per bundle (NDC 0409-1775-10) Limited Supply Available. Next Delivery: January 2023; Estimated Recovery: March 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Pfizer Customer Letter dated August 31, 2022

Other
Back to Top